Nuvation Bio (NUVB) Other financing activities (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Other financing activities of $9.4 million for Q4 2025, up 285.55% year-over-year from $2.4 million in Q4 2024, and up 922.64% quarter-over-quarter from -$1.1 million in Q3 2025.
Nuvation Bio (NUVB) Other financing activities (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Other financing activities for 6 consecutive years, with $9.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other financing activities rose 285.55% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at $9.6 million (up 92.66% YoY), while the FY2025 annual figure was $10.1 million, up 126.81% from the prior year.
- Other financing activities climbed to $9.4 million in Q4 2025 per NUVB's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Other financing activities topped out at $9.4 million in Q4 2025 and bottomed at -$5.1 million in Q4 2024.
- Historically, Other financing activities has averaged $859631.6 across 5 years, with a median of $298000.0 in 2023.
- Annual changes were most pronounced in 2021 — Other financing activities soared 5090.48% — and 2024, when it plunged 1452.53%.
- Nuvation Bio's Other financing activities stood at $230000.0 in 2021, then soared by 35.22% to $311000.0 in 2022, then rose by 20.58% to $375000.0 in 2023, then slumped by 1452.53% to -$5.1 million in 2024, then jumped by 285.55% to $9.4 million in 2025.
- Business Quant data shows NUVB's Other financing activities at $9.4 million in Q4 2025, -$1.1 million in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.78 Mn |
| Jun 30, 2026 | 57.78 Mn |
| Mar 31, 2026 | 908,000.00 |
| Mar 31, 2026 | 908,000.00 |
| Dec 31, 2025 | 9.41 Mn |
| Dec 31, 2025 | 9.41 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 534,000.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | -5.07 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | 3.21 Mn |
| Sep 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |